Similarly, PLAU plays a critical role in ECM degradation and has been linked to poor prognosis in several cancers, including head and neck squamous cell carcinoma (HNSCC) [27] and lung cancer [28], through its role in promoting metastasis. This evidence concerns the gene PLAU and head and neck squamous cell carcinoma.